Filing Details
- Accession Number:
- 0001209191-17-018049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-03 19:25:26
- Reporting Period:
- 2017-03-02
- Filing Date:
- 2017-03-03
- Accepted Time:
- 2017-03-03 19:25:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1400971 | L Bradley Campbell | C/O Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-02 | 49,050 | $8.00 | 127,475 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016.
Billionaire Hedge Funds
